v2.4.0.8
Net Income/(Loss) Per Share
9 Months Ended
Mar. 31, 2014
Earnings Per Share [Abstract]  
Net Income/(Loss) Per Share

3. Net Income/(Loss) Per Share

The computation of basic and diluted net income/(loss) per share was as follows (in thousands, except per share data):

 

     Three Months Ended      Nine Months Ended  
     March 31,      March 31,  
     2014     2013      2014      2013  

Numerator:

          

Net income/(loss)

   $ (40,056   $ 36,446       $ 12,217       $ 53,613   
  

 

 

   

 

 

    

 

 

    

 

 

 

Denominator:

          

Shares, basic

     35,685        32,234         34,212         32,552   

Effect of dilutive share-based awards

     —          1,901         2,320         1,291   
  

 

 

   

 

 

    

 

 

    

 

 

 

Shares, diluted

     35,685        34,135         36,532         33,843   
  

 

 

   

 

 

    

 

 

    

 

 

 

Net income/(loss) per share:

          

Basic

   $ (1.12   $ 1.13       $ 0.36       $ 1.65   
  

 

 

   

 

 

    

 

 

    

 

 

 

Diluted

   $ (1.12   $ 1.07       $ 0.33       $ 1.58   
  

 

 

   

 

 

    

 

 

    

 

 

 

Our basic net income/(loss) per share amounts for each period presented have been computed using the weighted average number of shares of common stock outstanding. Our diluted net income/(loss) per share amounts for each period presented include the weighted average effect of potentially dilutive shares. We use the “treasury stock” method to determine the dilutive effect of our stock options, deferred stock units, or DSUs, market stock units, or MSUs, and convertible notes.

Dilutive net income/(loss) per share amounts do not include the weighted average effect of 2,481,307 share-based compensation awards and convertible notes outstanding, and shares issuable for settlement of contingent consideration determined to be payable during the three months ended March 31, 2014, 1,055,896 share-based awards that were outstanding during the three months ended March 31, 2013, and 356,878 and 3,025,632 share-based awards that were outstanding during the nine months ended March 31, 2014 and 2013, respectively. These share-based awards were not included in the computation of diluted net income/(loss) per share because their effect would have been antidilutive.